The airway epithelium as a regulator of Th2 responses in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 4, 2011, Pages 390-392

  Fahy, John V ^a,b   Locksley, Richard M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 5; OX40 LIGAND; POLYPEPTIDE ANTIBIOTIC AGENT; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NK2 HOMEOBOX 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ASTHMA; CELL LINEAGE; CELLULAR IMMUNITY; CIGARETTE SMOKING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLOGY; DENDRITIC CELL; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; POLLUTION; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; TH2 CELL; TRANSCRIPTION REGULATION;

ANIMALS; FEMALE; HUMANS; MALE; NUCLEAR PROTEINS; PNEUMONIA; RESPIRATORY MUCOSA; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 80051811632     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201107-1258ED     Document Type: Editorial

References (11)

1. Tam A., Wadsworth S., Dorscheid D., Man S.F., Sin D.D. The airway epithelium: More than just a structural barrier. Ther Adv Respir Dis 2011; 5:255-273.
2. Parker D., Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol (In press)
3. Saenz S.A., Taylor B.C., Artis D. Welcome to the neighborhood: Epithelial cellderived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 2008;226:172-190.
4. Locksley R.M. Asthma and allergic inflammation. Cell 2010;140: 777-783.
5. Smith D.E. IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 2010;40:200-208.
6. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-1370.
7. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of t(h)2 cytokines by adipose tissue-associated c-kit(+)sca-1(+) lymphoid cells. Nature 2010;463:540-544.
8. Price A.E., Liang H.E., Sullivan B.M., Reinhardt R.L., Eisley C.J., Erle D.J., Locksley R.M. Systemically dispersed innate Il-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 2010;107:11489-11494.
9. Dougherty R.H., Sidhu S.S., Raman K., Solon M., Solberg O., Caughey G.H., Woodruff P.G., Fahy J.V. Accumulation of intraepithelial mast cells with a unique protease phenotype in Th2-high asthma. J Allergy Clin Immunol 2010;125:1046-1053.
10. Maeda Y., Chen G., Xu Y., Haitchi H.M., Du L., Keiser A.R., Howarth P.H., Davies D.E., Holgate S.T., Whitsett J.A. Airway epithelial transcription factor NKX2-1 inhibits mucous cell metaplasia and Th2 inflammation. Am J Respir Crit Care Med 2011;184:421-429.
11. Winslow M.M., Dayton T.L., Verhaak R.G., Kim-Kiselak C., Snyder E.L., Feldser D.M., Hubbard D.D., DuPage M.J., Whittaker C.A., Hoersch S., et al. Suppression of lung adenocarcinoma progression by NKX2-1. Nature 2011;473:101-104.